The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Impairment of PPARα and the Fatty Acid Oxidation Pathway Aggravates Renal Fibrosis during Aging
Open accessAbstract
Defects in the renal fatty acid oxidation (FAO) pathway have been implicated in the development of renal fibrosis. Although, compared with young kidneys, aged kidneys show significantly increased fibrosis with impaired kidney function, the mechanisms underlying the effects of aging on renal fibrosis have not been investigated. In this study, we investigated peroxisome proliferator–activated receptor α (PPAR α) and the FAO pathway as regulators of age-associated renal fibrosis. The expression of PPAR α and the FAO pathway–associated proteins significantly decreased with the accumulation of lipids in the renal tubular epithelial region during aging in rats. In particular, decreased PPAR α protein expression associated with increased expression of PPAR α-targeting microRNAs. Among the microRNAs with increased expression during aging, miR-21 efficiently decreased PPAR α expression and impaired FAO when ectopically expressed in renal epithelial cells. In cells pretreated with oleic acid to induce lipid stress, miR-21 treatment further enhanced lipid accumulation. Furthermore, treatment with miR-21 significantly exacerbated the TGF-β–induced fibroblast phenotype of epithelial cells. We verified the physiologic importance of our findings in a calorie restriction model. Calorie restriction rescued the impaired FAO pathway during aging and slowed fibrosis development. Finally, compared with kidneys of aged littermate controls, kidneys of aged PPAR α −/− mice showed exaggerated lipid accumulation, with decreased activity of the FAO pathway and a severe fibrosis phenotype. Our results suggest that impaired renal PPAR α signaling during aging aggravates renal fibrosis development, and targeting PPAR α is useful for preventing age-associated CKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
A comprehensive review on metabolic syndrome
Kaur, J. (2014) · Cardiology Research and Practice · doi:10.1155/2014/943162 · Cited by 1,889
RetractedOxyl radicals, redox-sensitive signalling cascades and antioxidants
Genestra, M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.04.009 · Cited by 4,930
Prevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895
MicroRNAs in Stress Signaling and Human Disease
Mendell, J. T., & Olson, E. N. (2012) · Cell · doi:10.1016/j.cell.2012.02.005 · Cited by 1,673
Lee, S. S.-T., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez-Salguero, P. M., Westphal, H., & Gonzalez, F. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3012 · Cited by 1,655
Self-citationKang, H. M., Ahn, S. H., Choi, P., Ko, Y.-A., Han, S. H., Chinga, F., Park, A. S. D., Tao, J., Sharma, K., Pullman, J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3762 · Cited by 1,555
Predictors of New-Onset Kidney Disease in a Community-Based Population
Fox, C. S. (2004) · JAMA · doi:10.1001/jama.291.7.844 · Cited by 1,241
Davies, D. F., & Shock, N. W. (1950) · Journal of Clinical Investigation · doi:10.1172/jci102286 · Cited by 1,133
Purushotham, A., Schug, T. T., Xu, Q., Surapureddi, S., Guo, X., & Li, X. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.02.006 · Cited by 1,003
Sorting out the roles of PPAR in energy metabolism and vascular homeostasis
Lefebvre, P. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27989 · Cited by 962
Transcriptional Regulation of Metabolism
Desvergne, B., Michalik, L., & Wahli, W. (2006) · Physiological Reviews · doi:10.1152/physrev.00025.2005 · Cited by 892
Structural and Functional Changes With the Aging Kidney
Denic, A., Glassock, R. J., & Rule, A. D. (2016) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2015.08.004 · Cited by 819
Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD
Montagner, A., Polizzi, A., Fouché, E., Ducheix, S., Lippi, Y., Lasserre, F., Barquissau, V., Régnier, M., Lukowicz, C., Benhamed, F., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310798 · Cited by 736
Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy
Herman-Edelstein, M., Scherzer, P., Tobar, A., Levi, M., & Gafter, U. (2014) · Journal of Lipid Research · doi:10.1194/jlr.p040501 · Cited by 645
The Aging Kidney: Physiological Changes
Weinstein, J. R., & Anderson, S. (2010) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2010.05.002 · Cited by 639
Cellular and molecular mechanisms in kidney fibrosis
Duffield, J. S. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72267 · Cited by 629
MicroRNA-21 Promotes Fibrosis of the Kidney by Silencing Metabolic Pathways
Chau, B. N., Xin, C., Hartner, J., Ren, S., Castano, A. P., Linn, G., Li, J., Tran, P. T., Kaimal, V., Huang, X., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003205 · Cited by 587
Poynter, M. E., & Daynes, R. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32833 · Cited by 550
The Association Between Age and Nephrosclerosis on Renal Biopsy Among Healthy Adults
Rule, A. D., Amer, H., Cornell, L. D., Taler, S. J., Cosio, F. G., Kremers, W. K., Textor, S. C., & Stegall, M. D. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-9-201005040-00006 · Cited by 503
Lipid accumulation in non-adipose tissue and lipotoxicity
van Herpen, N. A., & Schrauwen-Hinderling, V. B. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.11.049 · Cited by 500
Smad3-Mediated Upregulation of miR-21 Promotes Renal Fibrosis
Zhong, X., Chung, A. C. K., Chen, H.-Y., Meng, X.-M., & Lan, H. Y. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010111168 · Cited by 409
PPARs: diverse regulators in energy metabolism and metabolic diseases
Wang, Y.-X. (2010) · Cell Research · doi:10.1038/cr.2010.13 · Cited by 366
Renal lipid metabolism and lipotoxicity
Bobulescu, I. A. (2010) · Current Opinion in Nephrology and Hypertension · doi:10.1097/mnh.0b013e32833aa4ac · Cited by 364
MicroRNAs in kidney physiology and disease
Trionfini, P., Benigni, A., & Remuzzi, G. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.202 · Cited by 353
Regulation of SIRT1 in aging: Roles in mitochondrial function and biogenesis
Yuan, Y., Cruzat, V. F., Newsholme, P., Cheng, J., Chen, Y., & Lu, Y. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.02.003 · Cited by 299
Renal interstitial fibrosis: mechanisms and evaluation
Farris, A. B., & Colvin, R. B. (2012) · Current Opinion in Nephrology and Hypertension · doi:10.1097/mnh.0b013e3283521cfa · Cited by 298
SIRT1 in Type 2 Diabetes: Mechanisms and Therapeutic Potential
Kitada, M., & Koya, D. (2013) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2013.37.5.315 · Cited by 282
Role of Altered Renal Lipid Metabolism in the Development of Renal Injury Induced by a High-Fat Diet
Kume, S., Uzu, T., Araki, S.-I., Sugimoto, T., Isshiki, K., Chin-Kanasaki, M., Sakaguchi, M., Kubota, N., Terauchi, Y., Kadowaki, T., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007010089 · Cited by 278
Stevens, L. A., Viswanathan, G., & Weiner, D. E. (2010) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2010.03.010 · Cited by 270
Trevisan, R., Dodesini, A. R., & Lepore, G. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005121320 · Cited by 247
Sirt1 Activation Ameliorates Renal Fibrosis by Inhibiting the TGF‐β/Smad3 Pathway
Huang, X., Wen, D., Zhang, M., Xie, Q., Ma, L., Guan, Y., Ren, Y., Chen, J., & Hao, C. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24748 · Cited by 200
Simon, N., & Hertig, A. (2015) · Frontiers in Medicine · doi:10.3389/fmed.2015.00052 · Cited by 193
Yamakuchi, M. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00068 · Cited by 188
Aging-induced decrease in the PPAR-α level in hearts is improved by exercise training
Iemitsu, M., Miyauchi, T., Maeda, S., Tanabe, T., Takanashi, M., Irukayama-Tomobe, Y., Sakai, S., Ohmori, H., Matsuda, M., & Yamaguchi, I. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01051.2001 · Cited by 166
Modulation of PPAR in Aging, Inflammation, and Calorie Restriction
Sung, B., Park, S., Yu, B., & Chung, H. Y. (2004) · The Journals of Gerontology Series A · doi:10.1093/gerona/59.10.b997 · Cited by 145
Self-citationDeletion of Lkb1 in Renal Tubular Epithelial Cells Leads to CKD by Altering Metabolism
Han, S. H., Málaga-Diéguez, L., Chinga, F., Kang, H. M., Tao, J., Reidy, K. J., & Suszták, K. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014121181 · Cited by 134
Molecular mechanism of PPAR in the regulation of age-related inflammation
Chung, J. H., Seo, A. Y., Chung, S. W., Kim, M. K., Leeuwenburgh, C., Yu, B. P., & Chung, H. Y. (2008) · Ageing Research Reviews · doi:10.1016/j.arr.2008.01.001 · Cited by 132
Self-citationJiang, T., Liebman, S. E., Lucia, M. S., Li, J., & Levi, M. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00733.x · Cited by 123
Recent advances in calorie restriction research on aging
Chung, K. W., Kim, D. H., Park, M. H., Choi, Y. J., Kim, N. D., Lee, J., Yu, B. P., & Chung, H. Y. (2013) · Experimental Gerontology · doi:10.1016/j.exger.2012.11.007 · Cited by 108
Self-citationObesity and Change in Estimated GFR Among Older Adults
de Boer, I. H., Katz, R., Fried, L. F., Ix, J. H., Luchsinger, J. A., Sarnak, M. J., Shlipak, M. G., Siscovick, D. S., & Kestenbaum, B. R. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.07.018 · Cited by 108
Metabolomics of the interaction between PPAR‐α and age in the PPAR‐α‐null mouse
Atherton, H. J., Gulston, M. K., Bailey, N. J. C., Cheng, K., Zhang, W., Clarke, K., & Griffin, J. L. (2009) · Molecular Systems Biology · doi:10.1038/msb.2009.18 · Cited by 89
Effects of calorie restriction on cardioprotection and cardiovascular health
Ahmet, I., Tae, H., de Cabo, R., Lakatta, E. G., & Talan, M. I. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.04.015 · Cited by 87
Li, S., Mariappan, N., Megyesi, J. K., Shank, B. B., Kannan, K., Theus, S. A., Price, P. M., Duffield, J. S., & Portilla, D. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00309.2013 · Cited by 86
Jiang, T., Liebman, S. E., Lucia, M. S., Phillips, C. L., & Levi, M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080701 · Cited by 84
Human kidney free fatty acid and glucose uptake: evidence for a renal glucose-fatty acid cycle.
Meyer, C., Nadkarni, V., Stümvoll, M., & Gerich, J. E. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.3.e650 · Cited by 78
Sphingosine Kinase 2 Deficiency Attenuates Kidney Fibrosis via IFN-γ
Bajwa, A., Huang, L., Kurmaeva, E., Hong, Y., Dondeti, K. R., Chrościcki, P., Foley, L., Balogun, Z. A., Alexander, K. J., Park, H., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016030306 · Cited by 74
A Systems Approach to Reverse Engineer Lifespan Extension by Dietary Restriction
Hou, L., Wang, D., Chen, D., Liu, Y., Zhang, Y., Cheng, H., Xu, C., Sun, N., McDermott, J. R., Mair, W. B., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.02.002 · Cited by 72
Howroyd, P. C., Swanson, C., Dunn, C. S., Cattley, R. C., & Corton, J. C. (2004) · Toxicologic Pathology · doi:10.1080/01926230490515283 · Cited by 66
Atorvastatin reverses age‐related reduction in rat hepatic PPARα and HNF‐4
Sanguino, E., Roglans, N., Alegret, M., Sánchez, R. M., Vázquez‐Carrera, M., & Laguna, J. C. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706260 · Cited by 60
Targeting EMT to reverse renal fibrosis
Allison, S. J. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.133 · Cited by 58
Mori, Y., Hirano, T., Nagashima, M., Shiraishi, Y., Fukui, T., & Adachi, M. (2007) · Metabolism · doi:10.1016/j.metabol.2007.07.016 · Cited by 34
Cited by
Kidney fibrosis: from mechanisms to therapeutic medicines
Huang, R., Fu, P., & Ma, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01379-7 · Cited by 781
Signaling pathways of chronic kidney diseases, implications for therapeutics
Yuan, Q., Tang, B., & Zhang, C. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01036-5 · Cited by 453
Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease
Mitrofanova, A., Merscher, S., & Fornoni, A. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00741-w · Cited by 356
Molecular pathways that drive diabetic kidney disease
Mohandes, S., Doke, T., Hu, H., Mukhi, D., Dhillon, P., & Susztak, K. (2023) · Journal of Clinical Investigation · doi:10.1172/jci165654 · Cited by 341
Miao, J., Liu, J., Niu, J., Zhang, Y., Shen, W., Luo, C., Liu, Y., Li, C., Li, H., Yang, P., et al. (2019) · Aging Cell · doi:10.1111/acel.13004 · Cited by 281
Metadata
- Authors
- Chung, K. W., Lee, E. K., Lee, M. K., Oh, G. T., Yu, B. P., & Chung, H. Y.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2018-02-12
- Volume
- 29
- Issue
- 4
- Pages
- 1223-1237
- ISSN
- 1046-6673 (ISSN-L)
- 1533-3450
- OpenAlex
- W2788257045
- Cited by
- 288
- References
- 51
- FWCI
- 5.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.